NWPF

News ArchivesRead News

Northwestern Researchers Develop Milestone Parkinson's Treatment

Wednesday February 13, 2013

Ally Mutnick, Assistant Campus Editor

The Daily Northwestern - Northwestern researchers are continuing tests on their breakthrough development in the fight against Parkinson’s disease, a degenerative disorder that affects movement and coordination.

Toward the end of last year, chemistry Prof. Richard Silverman, and Dalton James Surmeier, chair of physiology at the Feinberg School of Medicine, created with their team a new family of compounds that could slow the progression of the disease.

So far, the compound has only been tested on animals, but experiments have produced successful results. However, researchers are now doing additional animal testing and working on turning the compound into a pill form, according to a Feb. 6 Chicago Tribune article.

The researchers believe their work can slow the disease without any serious side effects. Current treatment for Parkinson’s only targets the symptoms.

The new compound targets a rare faulty membrane protein that allows calcium to flood the dopamine neurons in the brain. These neurons control movement, and calcium interaction from Parkinson’s causes the cells to die, possibly leading to aging and premature death.

The researchers’ compound will selectively target the faulty protein and block calcium entry to stop cells from dying.

Surmeier and Silverman published their findings in the scientific journal Nature Communications on Oct. 23.

Recent News

Aug 24 - Study Details Process Involved in Parkinson’s Disease
Aug 20 - Two proteins work together to help cells eliminate trash; Parkinson's may result
Aug 17 - Scientists visualize critical part of basal ganglia pathways
Aug 17 - VA benefits office seeks all vets exposed to Agent Orange
Aug 12 - New, rapid dementia screening tool rivals 'gold standard' clinical evaluations
Aug 11 - Strolling in Seaside, fighting Parkinson's
Aug 11 - Scientists probing molecular origins of Parkinson's disease highlight two proteins
Aug 11 - Could Chocolate Help To Ease Parkinson’s Disease?
Aug 10 - Take 2: Why Seattle should try to replicate Spokane’s 3-on-3 Hoopfest success
Aug 10 - Book Review: A voyage into Parkinson’s disease, led by patient and journalist
Aug 10 - Parkinson's could be slowed with existing drug
Aug 7 - Opinion: Why modern life is making dementia in your 40s more likely
Aug 3 - Software Turns Smartphones into Tools for Medical Research
Jul 31 - Innovative Technology Using Dragonflies Might Offer Insights Into Human Brain Function
Jul 27 - Low-dose lithium reduces side effects from most common treatment for Parkinson's disease
Jul 27 - Opinion: Parkinson's disease creating class of workers who fear for their jobs: PennLive letters
Jul 22 - Parkinson's: Diabetes drug may offer clue to treatment
Jul 19 - Alzheimer's Drugs in the Works Might Treat Other Diseases, Too
Jul 17 - Parkinson's disease may be treatable with antimalaria drugs
Jul 16 - Virtual research studies feasible